Search - tctmd.com

Displaying 81 - 100 of 244

Sort: Relevancy | Date

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

January 15, 2020

ISCHEMIA Questions? Some Answers From David Maron

News Opinion Editor's Corner

ISCHEMIA Questions? Some Answers From David Maron

December 09, 2019

Off Script: After ISCHEMIA, the Devil Is in the (Design) Details

News Opinion Off Script

Off Script: After ISCHEMIA, the Devil Is in the (Design) Details

Ajay Kirtane, MD, SM

November 28, 2019

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

News Conference News AHA 2019

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

November 16, 2019

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

News Conference News AHA 2019

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

November 16, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

October 03, 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

September 09, 2019

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

News Daily News

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

August 05, 2019

Renal Denervation for Chagas Disease-Related HF Proves Safe in Pilot Study

News Daily News

Renal Denervation for Chagas Disease-Related HF Proves Safe in Pilot Study

August 01, 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Daily News

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

July 04, 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

News Industry News

Caretaker Medical Adds Continuous Beat-by-Beat Blood Pressure & Wireless Vitals to HealthSaaS Remote Patient Monitoring Platform

May 30, 2019

Registries Point to Lower Risk of Death With CABG vs PCI in Multivessel CAD

News Daily News

Registries Point to Lower Risk of Death With CABG vs PCI in Multivessel CAD

Michael O'Riordan

May 02, 2019

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

News Daily News

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

March 29, 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

March 11, 2019

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

News Conference News AHA 2018

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

Michael O'Riordan

November 11, 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.